Skip to main content
OpenTrials
Completed

NCT Number: NCT00247000

A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)

To demonstrate the safety, feasibility, quality of life, primary caregiver satisfaction, and cost effectiveness of integrated Home Telehealth care versus standard care in a heart failure clinic.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New Brunswick Heart Centre, Atlantic Health Sciences Corporation

Saint John, New Brunswick, B2L 4L2, Canada

About this study

We plan to implement and evaluate a Home Telehealth Care Management System designed to enhance clinical care for congestive heart failure patients who have difficulty with access to care. Unique in this model is that in addition to use of protocol driven interventions (evidence based), the primary care physician is intimately involved in follwo up of patients- with consequent reduction in the fracture of care seen in with attendance in multiple specialty clinics.

In this project, we will evaluate the delivery of care to heart failure patients in Nova Scotia and New Brunswick, with our intervention and the current standard of care, which is the heart failure clinic. Home Telehealth technology will allow patients to be contacted and regularly evaluated in a comprehensive way in their own home, and without the need for a clinic visit. While the Project Team (experienced in heart failure management) will monitor all data, the Family Physician will have first hand access to and right of first treatment when alterations in therapy are needed. This process will be facilitated by the use of protocol driven medical therapy, and delegated medical functions, as well as set-piece education. We hope, with this technology and care plan, to offer the benefits of disease management to this vulnerable patient population while at the same time firmly placing the Family Physician in their central role within the health care system. This program will enable a specific assessment of all aspects of the program, including outcomes, quality of life, professional satisfaction and cost.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patient Population Inclusion Criteria: Patients are eligible for participating in STARTEL if they satisfy all of the following inclusion criteria.

  • Male or female subject's ≥ 18 years of age with a diagnosis of Heart Failure
  • Subject must reside in either the Province of Nova Scotia or New Brunswick
  • Subject has been hospitalized for heart failure during the past two years or has a known history of heart failure for a minimum of two years.
  • Subject must have a dedicated working telephone line in their primary place of residence.
  • Subject must have a grounded electrical power supply in their primary place of residence.
  • Primary care physician provides their agreement to participate in STARTEL

Exclusion criteria

Patients are not eligible for participating in STARTEL if they meet any of the following exclusion criteria.

  • Inability to understand the English or French language or understand the study and provide informed consent.
  • Absence of a suitable area to conduct the home telehealth visit in the patient's place of residence.
  • Physical impairment, which would prohibit the successful completion of a home telehealth visit, including attachment of the peripheral equipment (BP cuff, ability to stand on a scale, etc).
  • In cases 1 & 3 only: a live in caregiver whose presence may overcome these limitations may allow the patient to be included in the study, however, only the patient's next of kin or duly appointed guardian (with documentation and with patient assent) may provide informed consent to participate).
  • Subject has a planned cardiac procedure such as open-heart surgery or percutaneous coronary intervention (PCI) within the next 6 months.
  • Subject has had cardiac surgery, percutaneous coronary intervention or a diagnosis of acute myocardial infarction within 1 month before randomization).
  • Condition where existing routine follow up occurs more than once weekly (i.e. hemodialysis, cancer treatment including: chemotherapy/radiation treatment). .
  • Patient is institutionalized (includes chronic care facility)

Treatment and study plan

Routine Care in a HF clinic vs Home Telehealth Care for HF

Device

Primary outcomes

  1. A composite of total all-cause hospitalizations and total mortality at one year.

    Time frame: 1 year

Secondary outcomes

  1. Heart failure morbidity and mortality

    Time frame: 1 year

  2. Cardiovascular hospitalization

    Time frame: 1 year

  3. Total number days in hospital

    Time frame: 1 year

  4. Total outpatient physician visits

    Time frame: 1 year

  5. Number of non-scheduled health visits outside the home

    Time frame: 1 year

  6. Total inpatient and outpatient health care costs

    Time frame: 1 year

  7. Kansas City Cardiomyopathy Quality of Life Score

    Time frame: 1 year

  8. Total medication related costs

    Time frame: 1 year

  9. Medication adherence(by prescription filling data)

    Time frame: 1 year

  10. Patient satisfaction as measured on Likert scale(1-10)

    Time frame: 1 year

  11. Primary care physician satisfaction (Likert scale)

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Nova Scotia Health Authority

Other

Collaborators

  • AstraZeneca
  • Atlantic Health Sciences Corporation
  • Canada Health Infoway
  • Continuing Care Nova Scotia
  • Heart and Stroke Foundation of Canada
  • Nova Scotia Telehealth Program

Registry information

Official study title

A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL

Important dates

Study start
2007
Primary completion
2009
Study completion
2012
First posted
Nov 1, 2005
Registry last updated
Oct 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.